Atrial Fibrillation Burden and Clinical Outcomes After Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs [0.03%]
导管消融与健康生活方式联合抗心律失常药物对房颤负担及临床结局的影响
Zuzana Hejdukova,Dalibor Herman,Marek Hozman et al.
Zuzana Hejdukova et al.
Background: PRAGUE-25 compared catheter ablation (CA) with lifestyle modification combined with antiarrhythmic drugs (LFM + AADs) in obese patients with atrial fibrillation (AF). ...
High Polygenic Risk of CAD Is Similar to That of Diabetes or Ischemic Stroke [0.03%]
高多基因冠心病风险相当于糖尿病或缺血性卒中的风险
Rami Hammoura,Mikael Åkerlund,Linda Holmquist Mengelbier et al.
Rami Hammoura et al.
Obesity Subphenotypes in Atrial Fibrillation: A Linked Electronic Health Record Study in the United Kingdom [0.03%]
英国电子健康记录的链接研究中的心房颤动肥胖亚表型
Hiroyuki Yoshimura,Chang Xu,Gregory Y H Lip et al.
Hiroyuki Yoshimura et al.
Background: Atrial fibrillation (AF) and obesity are increasingly prevalent and interrelated, but how body mass index (BMI) influences cardiovascular outcomes and mortality in AF patients at a population level remains unc...
Coronary Microvascular Dysfunction in Ischemia With Nonobstructive Coronary Arteries and Associations With Sublingual Microvascular Abnormalities [0.03%]
缺血性非冠状动脉阻塞性心脏病与舌下微血管异常的关系
Nathaniel R Smilowitz,Abel Salas,Amanda Joa et al.
Nathaniel R Smilowitz et al.
Background: Coronary microvascular dysfunction (CMD) is a mechanism of ischemia with nonobstructive coronary arteries (INOCA) diagnosed by invasive coronary function testing (CFT). It is unknown whether CMD reflects a sys...
Simran Makker,Samarra Badrouchi,Dongchu Xu et al.
Simran Makker et al.
Prediabetes, Malignant Left Ventricular Hypertrophy, and Risk of Incident Heart Failure Among Hypertensive Adults [0.03%]
高血压患者的糖耐量异常、恶性左心室肥厚与新发心力衰竭风险的关系
Arnaud D Kaze,Stephen P Juraschek,Jordana B Cohen et al.
Arnaud D Kaze et al.
Background: Prediabetes is common among adults with hypertension, but its contribution to heart failure (HF) risk, particularly in the presence of subclinical myocardial abnormalities, remains uncertain. ...
Cardioprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors: What Have We Learned So Far? [0.03%]
钠葡萄糖共转运蛋白2抑制剂的心脏保护机制：我们目前了解多少？
Lei Qi,Ernest M Wright,Xinjiang Cai
Lei Qi
Paschalis Karakasis
Paschalis Karakasis
Timothy J H Lathlean,Rajiv Mahajan
Timothy J H Lathlean
Genetic Testing After Heart Transplantation Uncovers Heritable Disease and Drives Family Screening [0.03%]
心脏移植后的基因检测发现可遗传疾病并推动家族筛查
Carlos Moliner-Abós,Diego Cabrera Argaña,David Belmar Cliville et al.
Carlos Moliner-Abós et al.
Background: Genetic testing (GT) is established in ambulatory cardiomyopathy (CM), but its utility after heart transplantation (HTx) recipients remains poorly characterized. ...